25k patients administered
99.8% were OK.
0.18% adverse effects
0.02% died (5 patients).
In CDK patients, Epogen has *****5%***** overall adverse effects (adverse + letal).
I think it's worth to dig a little on data.
But in the near term, this stock is finished..... unless tomorrow they say "we are recalling all boxes because update in datasheets".
Nevertheless, this event has been really bad managed, both from Company & FDA (1 week ago they said the administration to go on).
There are many healthcare employees with a very purfunctory attitude, they feel underpaid, overworked, and generally just not appreciated, we are under their care sometimes at our worst moments in our life.......they alone could be the reasons for the very minute problems with Omontys.
Some of these people in no way should be responsible for anyone else's healthcare.
This is a simple fact.
In my opinion, that is one place I would start looking.